COMMENT Biologic sales forecast to pass innovative small molecule sales in next five years The telemedicine community has rallied to provide support to patients in Ukraine Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments Supply Chain CMO agreements need to go public, but ‘glib’ onshoring not the answer A new report commissioned by the US Congress recommends that the FDA should make drug supply chain information public. Fiona Barry writes about the potential implications. insight Europe reports the highest prevalence of chronic cough comment Could vaccine hesitancy impact hearing disorders? Biologic sales forecast to pass innovative small molecule sales in next five years The telemedicine community has rallied to provide support to patients in Ukraine Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments 06/01/2022 13:43:12
Biologic sales forecast to pass innovative small molecule sales in next five years
The telemedicine community has rallied to provide support to patients in Ukraine
Osteoarthritis pipeline shifting from analgesics to disease-modifying treatments